NOVARTIS INDIA LTD. - 500672 - Corporate Action-Board approves Dividend
The Board has recommended final dividend of Rs. 10 per equity share (of the face value of Rs. 5 each) for the financial year ended March 31, 2022, subject to the approval of the shareholders of the Company at the ensuing Annual General Meeting ('AGM'). Accordingly, the said final dividend, if approved by the shareholders, will be paid on or after August 2, 2022. NOVARTIS INDIA LTD. - 500672 - Outcome Of The Meeting Of The Board Of Directors Of Novartis India Limited ('The Company') Held On May 19, 2022
Outcome of the Meeting of the Board of Directors of Novartis India Limited ('the Company') held on May 19, 2022 NOVARTIS INDIA LTD. - 500672 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Novartis India Limited ('The Company') Held On May 19, 2022
Outcome of the Meeting of the Board of Directors of Novartis India Limited ('the Company') held on May 19, 2022 NOVARTIS INDIA LTD. - 500672 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayNOVARTIS INDIA LTD. 2CINL24200MH1947PLC006104 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY 0 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Nikhil Malpani Designation: Company Secretary and Compliance Officer EmailId: nikhil_satish.malpani@novartis.com Name of the Chief Financial Officer: MD is signing on behalf of CFO Designation: Managing Director EmailId: india.investors@novartis.com Date: 30/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. NOVARTIS INDIA LTD. - 500672 - Certificate Under Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended March 31, 2022
Certificate under Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the financial year ended March 31, 2022. This is for your information and record. NOVARTIS INDIA LTD. - 500672 - Authorizing Key Managerial Personnel For Determining Materiality Of An Event Or Information And For The Purpose Of Making Disclosures Under Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 By The Board
Authorizing Key Managerial Personnel for determining Materiality of an event or information and for the purpose of making disclosures under Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 by the Board NOVARTIS INDIA LTD. - 500672 - Appointment of Company Secretary and Compliance Officer
Appointment of Company Secretary and Compliance Officer of the Company NOVARTIS INDIA LTD. - 500672 - Announcement under Regulation 30 (LODR)-Change in Management
Change in management - Appointment of Chief Financial Officer of the Company NOVARTIS INDIA LTD. - 500672 - Outcome Of The Meeting Of The Board Of Directors Of Novartis India Limited Held On Wednesday, April 27, 2022
Outcome of the Meeting of the Board of Directors of Novartis India Limited held on Wednesday, April 27, 2022 for : 1. Appointment of Chief Financial Officer 2. Appointment of Company Secretary and Compliance Officer NOVARTIS INDIA LTD. - 500672 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that as per the information received from the Company's Registrar and Share Transfer Agent on April 21, 2022, shareholder has reported the loss of share certificates as detailed in the attachment. Request you to take the same on record as required under the provisions of the said Regulation.